Corteneinc
1 known investors
Find your way into Corteneinc
59 people in our graph share verified history with the Corteneinc team — schools, employers, funds. One of them is your warm intro.
Robert Peaseunlockedknows Michael Corbett · together at Actuate Corporation (overlapped)
knows the team · via CRC Health Group
×2knows the team · via Infogain
×4knows the team · via Actuate Corporation
×4knows the team · via Curtin University
Cortene is developing a patent-protected, peptide-based drug targeting the brain signaling believed to underlie acquired chronic diseases such as Parkinson's, Alzheimer's, dysautonomia, autoimmunity, and ME/CFS. The company operates in biotech, focusing on the root causes of brain-centric chronic conditions.
Founders & leadership
GP
Gerard PereirainFounder, President & CEO
SC
Sanjay ChandainChief Development Officer
MC

Michael CorbettinChief Business OfficerMichael Corbett brings enterprise software architecture and business analysis expertise, with a background implementing large-scale applications across CRM, business intelligence, and system integration platforms including Salesforce and Cognos.
Investors · 1
Competitors · 2
by search overlap1Mg4 shared keywordsThis is a product listing page on an online pharmacy for Tugain Twins 5 Solution, a topical minoxidil-based medicine sold to treat hair loss and promote hair regrowth. The page provides usage instructions, benefits, side effects, and purchase/return details rather than describing a company.
Clene3 shared keywordsClene is a clinical-stage biopharmaceutical company developing nanotherapeutics that target cellular energy impairments to treat neurodegenerative diseases and restore neuronal health. Its platform produces clean-surfaced, catalytically-active nanocrystals for therapeutic use.
Companies competing with Corteneinc for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Corteneinc do?
- Cortene is developing a patent-protected, peptide-based drug targeting the brain signaling believed to underlie acquired chronic diseases such as Parkinson's, Alzheimer's, dysautonomia, autoimmunity, and ME/CFS. The company operates in biotech, focusing on the root causes of brain-centric chronic conditions.
- Who founded Corteneinc?
- Corteneinc was founded by Gerard Pereira.
- Who are Corteneinc's investors?
- Corteneinc's investors include Lauder Partners.

